MIMS online
LightNews LightNews
banner
mimsonline.bsky.social
MIMS online
@mimsonline.bsky.social
20 followers 18 following 270 posts
Posts Replies Media Videos
mimsonline.bsky.social
This week's news in brief:

▶️ Prescribers reminded of oral semaglutide dose error risk

▶️ First low-carbon pMDI reaches UK patients

Read more on MIMS
buff.ly/xRV9cEE
December 19, 2025 at 2:04 PM
mimsonline.bsky.social
Gefapixant is now available for NHS prescribing, although it has not been appraised by NICE
First new cough treatment in 50 years launched for NHS prescribing
Gefapixant is now available for NHS prescribing, although it has not been appraised by NICE.
buff.ly
December 19, 2025 at 9:01 AM
mimsonline.bsky.social
This week's updated #drugshortages include:

▶️ Rivastigmine transdermal patches (some brands)

▶️ Quetiapine modified-release tablets (some brands)

▶️ Seretide Accuhaler

For more information, see the MIMS drug shortages tracker buff.ly/1opQYsS
December 17, 2025 at 12:00 PM
mimsonline.bsky.social
New conditions have been included in the UKMEC eligibility criteria for contraception, which have been updated for the first time since 2019 buff.ly/cMhINvb
UKMEC contraceptive eligibility criteria updated
New conditions have been included in the UKMEC eligibility criteria for contraception, which have been updated for the first time since 2019 by the College of Sexual and Reproductive Healthcare.
buff.ly
December 17, 2025 at 9:51 AM
mimsonline.bsky.social
Hypoglycaemics, including GLP-1 agonists, are associated with some skin conditions, according to the GP author of a new CPD module.

Read more on MIMS
GLP-1 agonists and other hypoglycaemics linked to some skin conditions, GP advises
Hypoglycaemics, including GLP-1 agonists, are associated with some skin conditions, according to the GP author of a new CPD module.
buff.ly
December 13, 2025 at 2:01 PM
mimsonline.bsky.social
This week's news in brief

▶️ Nifedipine once-daily tablets out of stock

▶️ Estradot shortage continues

▶️ Naproxen now available OTC for musculoskeletal pain

Read more on MIMS
buff.ly/xRV9cEE
December 12, 2025 at 2:00 PM
mimsonline.bsky.social
Slow tapering of antidepressants with psychological support prevents depression relapse to a similar extent as continuing drug treatment, evidence from a systematic review and meta-analysis indicates.

Read more on MIMS
Slow antidepressant tapering plus psychotherapy as effective as continuing medication, meta-analysis finds
Slow tapering of antidepressants with psychological support prevents depression relapse to a similar extent as continuing drug treatment, evidence from a systematic review and meta-analysis indicates.
buff.ly
December 12, 2025 at 10:01 AM
mimsonline.bsky.social
Lack of support for patients switching inhalers may be undermining the progress made in asthma care since the publication of the joint NICE/BTS/SIGN guideline last year, according to a report from Asthma + Lung UK.

Read more on MIMS
Progress in asthma care driven by NICE/BTS/SIGN guidance undermined by lack of support for patients switching treatment regimens
Lack of support for patients switching inhalers may be undermining the progress made in asthma care since the publication of the joint NICE/BTS/SIGN guideline last year, according to a report from…
buff.ly
December 11, 2025 at 5:00 PM
mimsonline.bsky.social
This week's #drugshortages

▶️ Cabaser 1mg tablets (cabergoline)

▶️ Exelon Transdermal Patch, 4.6mg/24hr, 9.5mg/24hr and 13.3mg/24hr (rivastigmine)

▶️ Fortipine LA (nifedipine)

For more information, see the MIMS drug shortages tracker
buff.ly/5G6YJlJ
December 10, 2025 at 2:00 PM
mimsonline.bsky.social
Thousands of patients are being prescribed suboptimal adrenaline pen doses, an analysis of NHS prescribing data suggests.

Find out more on MIMS
buff.ly/nKrjNtI
Widespread underdosing of adrenaline auto-injectors found in primary care across England
Thousands of patients are being prescribed suboptimal adrenaline pen doses, an analysis of NHS prescribing data suggests.
www.mims.co.uk
December 9, 2025 at 12:55 PM
mimsonline.bsky.social
CGM is associated with improved clinical outcomes in older insulin-treated adults with dementia compared with fingerprick testing, according to a cohort study.

Read more on MIMS
CGM improves outcomes in older diabetes patients with dementia, study suggests
CGM is associated with improved clinical outcomes in older insulin-treated adults with dementia compared with fingerprick testing, according to a cohort study.
buff.ly
December 6, 2025 at 2:30 PM
mimsonline.bsky.social
This week's news in brief

▶️ Warning of incorrect glucose readings with some FreeStyle Libre 3 sensors

▶️ Oral GLP-1 drug shows no benefit in Alzheimer's disease

Read more on MIMS
buff.ly/hHR5r8m
December 5, 2025 at 3:03 PM
mimsonline.bsky.social
Patients with epilepsy are facing challenging and often unreported drug shortages, leading to potentially unsafe medication switching, a survey has found.

Read more on MIMS
Unreported drug shortages and inappropriate switching posing serious risks for patients with epilepsy, survey finds
Patients with epilepsy are facing challenging and often unreported drug shortages, leading to potentially unsafe medication switching, a survey has found.
buff.ly
December 5, 2025 at 10:00 AM
mimsonline.bsky.social
Some strengths of rivastigmine transdermal patches are in limited supply until mid-December.

Read more on MIMS
Alzheimer's disease drug patches in short supply
Some strengths of rivastigmine transdermal patches are in limited supply until mid-December.
buff.ly
December 4, 2025 at 3:00 PM
mimsonline.bsky.social
HRT tablet re-launched after almost 7 years

Read more on MIMS
HRT tablet re-launched after almost 7 years
Angeliq (estradiol/drospirenone) was discontinued in 2019 for commercial reasons.
buff.ly
December 4, 2025 at 10:00 AM
mimsonline.bsky.social
The thresholds that NICE uses to assess the cost-effectiveness of medicines will increase from April 2026 following a new UK–US pharmaceutical trade deal.

Read more on our sister site #MIMSPharma
NICE cost-effectiveness thresholds to increase
The thresholds that NICE uses to assess the cost-effectiveness of medicines will increase from April 2026 following a new UK–US pharmaceutical trade deal.
buff.ly
December 3, 2025 at 4:00 PM
mimsonline.bsky.social
This week's updated #drugshortages

▶️ Etopophos (etoposide)

▶️ Frisium (clobazam)

▶️ Hemabate (carboprost)

For more information, see the MIMS drug shortages tracker
buff.ly/5G6YJlJ
December 3, 2025 at 2:00 PM
mimsonline.bsky.social
Commonly available preparations to treat acute otitis externa in primary care are summarised in a handy table in an updated MIMS Learning module. Find out more about what the module has to say about antibiotic prescribing for this condition on MIMS

buff.ly/Zgt3SzE
New acute otitis externa learning module provides quick-reference table of treatments
Commonly available preparations to treat acute otitis externa in primary care are summarised in a handy table in the updated MIMS Learning module.
buff.ly
November 28, 2025 at 5:34 PM
mimsonline.bsky.social
This week's news in brief

▶️ Branded antispasmodics discontinued

▶️ Third SGLT2 inhibitor licensed for paediatric use

▶️ Isosorbide mononitrate modified-release tablets available in new strength

Read more on MIMS
buff.ly/hYWTr3w
November 28, 2025 at 11:00 AM
mimsonline.bsky.social
GLP-1 agonists are associated with an increased risk of new chronic cough in people with type II diabetes, according to a large, multicentre, cohort study.

Read more on MIMS
GLP-1 agonists linked with an increased risk of chronic cough
GLP-1 agonists are associated with an increased risk of new chronic cough in people with type II diabetes, according to a large, multicentre, cohort study.
buff.ly
November 27, 2025 at 3:01 PM
mimsonline.bsky.social
This week's #DrugShortages

▶️ Almuriva 4.6mg/24hr, 9.5mg/24hr and 13.3mg/24hr patches (rivastigmine)

For more information, see the MIMS Drug Shortages Tracker
buff.ly/MAQ5QJI
November 26, 2025 at 11:00 AM
mimsonline.bsky.social
Methylphenidate availability for ADHD prescribing has improved with the launch of a new preparation, and a new chewable version is set to launch next year.

Find out more on MIMS Pharma
Methylphenidate supply improves as new preparation introduced and ongoing shortage eases
The availability of methylphenidate for ADHD prescribing has improved with the launch of a new product, resupply of an existing preparation, and a new chewable version set to launch next year.
buff.ly
November 24, 2025 at 2:00 PM
mimsonline.bsky.social
Pharmacological therapy in people with COPD should now be escalated after a moderate, rather than a severe, exacerbation, the draft 2026 GOLD report recommends.

Read more on MIMS
Escalate therapy in people with COPD at an earlier stage, draft GOLD report recommends
Pharmacological therapy in people with COPD should now be escalated after a moderate, rather than a severe, exacerbation, the draft 2026 GOLD report recommends.
buff.ly
November 22, 2025 at 2:02 PM
mimsonline.bsky.social
This week's news in brief

▶️ Tirzepatide highly effective for weight loss in PCOS

Read more on MIMS
buff.ly/hYWTr3w
November 21, 2025 at 12:00 PM
mimsonline.bsky.social
Antihypertensives should be deprescribed in older people with severe frailty because the harms of the medications probably outweigh the benefits, the British Geriatrics Society has advised.

Read more on MIMS
Deprescribe antihypertensives in older, severely frail people, British Geriatrics Society advises
Antihypertensives should be deprescribed in older people with severe frailty because the harms of the medications probably outweigh the benefits, the British Geriatrics Society has advised.
buff.ly
November 20, 2025 at 2:00 PM